5 July 2015

Biogen, an international biotechnology company, announced to invest one billion francs for a new biological manufacturing facility in Luterbach in the canton of Solothurn. A pre-contract with the Canton of Solothurn for the purchase of the land has been concluded. The consummation of the land purchase and the beginning of the construction work shall be at the end of 2015. By 2019 the plant should be operational, creating 400 jobs and producing biopharmaceutical medicine. VISCHER advises Biogen in the land purchase, the VISCHER Team including Dr. Andreas C. Albrecht (Managing Partner), Dr. David Jenny (Partner), Dr. Roland M. Müller (Partner) and Mathias Kuster (Senior Associate).

Categories: Real Estate, Life Sciences, Pharma, Biotech

You are currently offline. Some pages or content may fail to load.